The causes for, and ways to improve, the diagnostic delays in patients with psoriasis who progress to psoriatic arthritis are discussed.
Margareth Pierre-Louis, MD, MBA, FAAD discusses issues pertaining to skin cancer in people with skin of color as well as recommendations for the provision of multi-ethnic dermatology care.
Even though it is often thought of as a skin condition, many forms of epidermolysis bullosa are truly multisystem disorders, which makes coordinating the care complex.
Clinician competence in treating patients of various racial and ethnic backgrounds and the critical need for greater inclusion of diverse populations in trials investigating the pathophysiology and treatment of AD are underscored.
The pressing need to clarify risk factors and effective interventions for skin of color populations is underscored.
A roundtable discussion by experts in issues facing patients with skin of color reveals interesting insights.
Bioprinting for burns and other severe wounds could significantly accelerate wound closure and healing, reduce the risk for infection and minimize scarring.
The off-label use of treatments is especially prevalent in dermatology as the need for effective therapies outpaces the approval process. Experts discuss the most commonly employed treatments, the ethical implications of off-label use, and the need for patient education.